ArticleAnalgesic effects of dynorphin-A and morphine in mice
References (16)
- et al.
Dynorphin: A possible modulatory peptide on morphine or β-endorphin analgesia in mouse
Eur J Pharmacol
(1981) - et al.
Antinociceptive profile of dynorphin in rats
Life Sci
(1983) - et al.
Intrathecal morphine in mice: a new technique
Eur J Pharmacol
(1980) - et al.
Sites of analgesic action of dynorphin
Life Sci
(1983) - et al.
Analgesic activity of intraspinally administrated dynorphin and ethylketocyclazocine
Eur J Pharmacol
(1982) - et al.
Mixed opioid/nonopioid effects of dynorphin and dynorphin relayed peptides after their intrathecal injection in rats
Neuropeptides
(1983) - et al.
Analgesic effects of μ-, δ- and κ-opiate agonists and, in particular, dynorphin at the spinal level
Life Sci
(1983) - et al.
A modification of Haffner's method for testing analgesia
Jpn J Pharmacol
(1966)
Cited by (39)
Supraspinal antinociceptive effect of apelin-13 in a mouse visceral pain model
2012, PeptidesCitation Excerpt :Therefore, the present study was conducted to further investigate the relationship between supraspinal apelin and classical opioid receptors agonist morphine. The analgesic effect of i.c.v. morphine in our result is consistent with the previous report [25]. The APJ receptor agonist apelin-13 (0.3 μg/mouse, i.c.v.) could significantly potentiate the analgesia of 2.5 μg/kg and 5 μg/kg morphine (Fig. 4A).
Long-lasting antinociceptive spinal effects in primates of the novel nociceptin/orphanin FQ receptor agonist UFP-112
2010, PainCitation Excerpt :In rodent assays investigating a variety of physiological functions, UFP-112 consistently mimicked the effects of N/OFQ with markedly higher potency and longer duration of action [6]. Given that intrathecal morphine-induced antinociception only last for 1–2 h in rodents [4,27] and the duration of antinociception can be distinguished between intrathecal morphine (4–5 h) and N/OFQ (2–3 h) in monkeys [19], it is important to examine whether the high potency and long duration of action of UFP-112 can translate to non-human primates in the absence of an itch side effect. Therefore, the aim of this study was to investigate the pharmacological profile of intrathecally administered UFP-112 in monkeys.
A Prolonged Nitric Oxide-Dependent, Opioid-Mediated Antinociceptive Effect of Hyperbaric Oxygen in Mice
2009, Journal of PainCitation Excerpt :When mice were pretreated with a cocktail of DYN AS and β-EP AS, the HBO2-induced antinociceptive effect was reduced by two-thirds; however, this was not significantly different from the DYN AS-antagonized response to HBO2. It would appear that DYN—an opioid peptide with known antinociceptive properties18,22—is the primary mediator of HBO2-induced antinociception. Once again, this is similar to observations made in studies of N2O-induced antinociception.
Neuroregulatory peptides of central nervous system origin: From laboratory to clinic
2009, Hormones, Brain and Behavior OnlineDynorphin-mediated antinociceptive effects of l-arginine and SIN-1 (an NO donor) in mice
2006, Brain Research Bulletin